Please enable Javascript to use all features and improve your user experience.
GfV 2024
Programme
Posters
People
Search
EN
Back
Poster Session
Poster exhibition
Vaccines
Appointment
Date:
25/03/2024
Time:
13:00
–
21:00
Location / Stream:
Vaccines
Programme
Poster
P 120
Development of swine Fc-conjugated serotype O foot-and-mouth disease virus-like particles and immunological evaluation in swine
Dr. Hyunjin Shin (Taejon / KR)
Vaccines
Poster
P 121
Targeting immune evasion in HCMV vaccine strategies
Dr. Katja Hoffmann (Freiburg / DE)
Vaccines
Poster
P 122
A formulated mucosal inactivated whole RSV vaccine protects mice in a challenge model
Valentina Eberlein (Leipzig / DE)
Vaccines
Poster
P 123
Safety and immunogenicity of mRNA-based seasonal influenza vaccines including hemagglutinin and neuraminidase antigens in adults
Dr. Kristina Dobrindt (München / DE)
Vaccines
Poster
P 124
Research on vaccine strategies against flaviviruses
Rebecca Weiß (Leipzig / DE)
Vaccines
Poster
P 125
Establishment and validation of a computational vaccine development pipeline for emerging viral diseases – A case study on Junin virus
Dr. Antonia Sophia Peter (Leipzig / DE)
Vaccines
Poster
P 126
Opening the doors for rapid reverse genetics, modifications and
in vitro
evolution of mastadenoviruses
Julian Fischer (Freiburg / DE)
Vaccines
Poster
P 127
Computational design of epitope-scaffolds targeting pan-coronavirus neutralizing antibody lineages
Tom Uwe Schlegel (Leipzig / DE)
Vaccines
Poster
P 128
Large-scale one-to-stop codon modifications produce live-attenuated SARS-CoV-2 vaccines that show preclinical safety and efficacy
Dr. Güliz Tuba Barut (Bern / CH)
Vaccines
Poster
P 129
Impact of helminth infection on the efficacy of COVID-19 mRNA vaccine in mice
Dr. Jinpeng Su (München / DE)
Vaccines
Poster
P 130
Development in vitro models and viral vectors and for gene replacement therapy of calpainopathy (LGMD2A/R1)
Dr. Eric Ehrke-Schulz (Witten / DE)
Vaccines
Poster
P 131
Immunogenicity and efficacy of mRNA-1345, an mRNA-Based RSV Vaccine, in BALB/c mice and cotton rats
Dr. Sarah Adams (München / DE)
Vaccines
Poster
P 132
Investigating the therapeutic potential of an immune-modulatory cargo-expressing oncolytic virus in a mixed tumor model
Jasmin Hatami (Innsbruck / AT)
Vaccines
Poster
P 133
Development of an efficient vaccine against porcine reproductive and respiratory syndrome virus
Kristina Kissner (Greifswald - Insel Riems / DE)
Vaccines
Poster
P 134
Recombinant antigen fused to vaccinia virus B5 improves antigen-specific humoral responses by MVA vaccines
Dr. Sha Tao (Düsseldorf / DE)
Vaccines
Poster
P 135
Emergence of Bluetongue virus serotype 3 in the Netherlands and development of an experimental infection model in sheep
Dr. Melle Holwerda (Lelystad / NL)
Vaccines
Poster
P 136
Single MVA-SARS-2-ST/N vaccination rapidly protects K18-hACE mice against a lethal SARS-CoV-2 challenge infection
Sabrina Clever (Hannover / DE)
Vaccines
Poster
P 137
Rapid protective MVA-SARS-2-ST vaccination induces robust T cell responses against SARS-CoV-2 in Syrian hamsters
Christian Meyer zu Natrup (Hannover / DE)
Vaccines
Poster
P 138
Optimization of trans-amplifying mRNA vaccine vector by directed evolution and rational approach
Dr. Mario Perkovic (Mainz / DE)
Vaccines
Poster
P 139
Utility of live-attenuated measles virus to generate immunogenic anti-Bunyavirus vaccine candidates
Dr. Mohamed Rasheed Gadalla (Langen / DE)
Vaccines
Poster
P 140
A comprehensive risk assessment algorithm guided SARS-CoV-2 vaccine composition strategy
Dr. Kristina Dobrindt (München / DE)
Dr. Emilio Fumero (Basel / CH)
Dr. Sarah Adams (München / DE)
Dr. Jennifer Tufts (München / DE)
Vaccines
Poster
P 141
Depletion of production-related impurities improves the performance of self-amplifying RNA
Evelin Nett (Mainz / DE)
Vaccines
Poster
P 142
A broad-spectrum human Papillomavirus vaccine based on a recombinant measles virus vector
Mona V. Lange (Langen / DE)
Vaccines
Poster
P 143
Impact of heterologous MVA-booster vaccination on SARS-CoV-2 specific immune responses in a Golden Syrian Hamster model for Coronavirus disease 2019 (COVID-19)
Sabrina Clever (Hannover / DE)
Vaccines
Poster
P 144
Defective interfering particles as a potential mucosal influenza vaccine
Maike Bälkner (Magdeburg / DE)
Vaccines
Poster
P 145
Evaluation of T- and B-cell immunity after HPV vaccination by multi-colour elispot on a single cell level
Rosemarie Preyer (Strassberg / DE)
Vaccines
Poster
P 146
The potential of arenavirus vector therapy for treatment of cancer and chronic infectious diseases
Dr. Timo Schippers (Vienna / AT)
Vaccines
Poster
P 147
Comparative analysis of virus-host ínteractions and transcriptional responses to infection identifies signatures associated with YFV vaccine strain attenuation
Dr. Richard J. P. Brown (Bochum / DE)
Vaccines
Poster
P 148
Immunological characterization of nanoparticle-based SARS-CoV-2 mRNA vaccines for subsequent mucosal application
Julia Rudert (München / DE)
Vaccines
Poster
P 150
Engineering a functionalized RNA transfer system based on retroviral capsid design
Yu-Hsun Chen (Heidelberg / DE)
Vaccines
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy